A U.S. peptide client searched for products on Google, found Bloom Tech, and sent an inquiry expressing interest in shipping the products to Vietnam. After the sales representative explained that we have extensive experience shipping to Vietnam, the client purchased two sample boxes of Bloom Tech's TB 500 5mg and Retatrutide 5mg. Upon receipt, the client was very pleased, noting the excellent product quality, and indicated they would place another order next month. Payment was made via international bank transfer, and shipment was arranged immediately afterward. Using our dedicated Vietnam shipping route, the customer received the package within 7 days. They noted that the entire transaction process was flawless and expressed hope for continued long-term cooperation.
 |
 |
 |
 |
 |
 |
Client Discovery and Initial Contact
We are always at your service when you need
While searching for "peptide API shipping to Vietnam" on Google Scholar, Wilson used academic keywords to pinpoint Bloom Tech's official website.
This client specializes in the research and development of drugs for sports medicine and metabolic diseases and urgently needed APIs compliant with WADA standards for clinical trials. The product specifications and preclinical data for TB500 and Retatrutide displayed on Bloom Tech's website piqued the client's interest, particularly the mention of "experience with dedicated shipping routes to Vietnam."
In-Depth Analysis of Product Characteristics
This product consists of 43 amino acids and has a molecular weight of 4,987 Da following acetylation modification, with a purity of ≥99.5%. Its core mechanism of action involves promoting cell migration by upregulating actin expression. In a rat model of muscle strain, a 2 mg/kg dose reduced muscle strength recovery time by 40% and increased collagen deposition by 50%.
Preclinical studies indicate that its angiogenic effects accelerate wound healing by 30% and reduce scar area by 40%. Particularly in the cardiovascular field, in a mouse model of myocardial infarction, TB500 reduced myocardial fibrosis by 35% and increased ejection fraction by 20%. This product has passed SGS heavy metal testing, with lead/cadmium content <0.1 ppm, meeting USP <232> standards.
As a triple receptor agonist targeting GLP-1, GIP, and glucagon, its 39-amino acid structure is modified with γ-Glu-2xAdo to achieve an albumin binding rate of >95%. Phase II clinical data show that in obese patients, the 12 mg dose group achieved 24.2% weight loss, an 82.4% reduction in hepatic fat content, and a 30% decrease in non-HDL cholesterol over 48 weeks.
Preclinical studies indicate that its angiogenic effects accelerate wound healing by 30% and reduce scar area by 40%. Particularly in the cardiovascular field, in a mouse model of myocardial infarction, TB500 reduced myocardial fibrosis by 35% and increased ejection fraction by 20%. This product has passed SGS heavy metal testing, with lead/cadmium content <0.1 ppm, meeting USP <232> standards.
Customer Feedback and Long-Term Collaboration Mechanisms
01
Dr. James Carter, Director of the client's laboratory, commented: "The sample quality far exceeded expectations, and TB500's muscle repair effects, in particular, demonstrated remarkable potential in canine models. Retatrutide's triple mechanism has performed exceptionally well in the treatment of metabolic syndrome, and we plan to include it in Phase II clinical trials. "
02
The client particularly praised Bloom Tech's "research sharing" mechanism, which provides regular access to the latest clinical data. In the field of fatty liver disease treatment, the two parties are collaborating to develop a combination therapy of Retatrutide and an FXR agonist, which further reduces liver fat content by 20%.
03
Regarding logistics, the client highly praised the timeliness of the "Vietnam Dedicated Line": "Delivery within 7 days with perfect temperature control-30% faster than our previous European supplier."
04
The client specifically mentioned the blockchain traceability system, praising it for "end-to-end traceability from production to delivery, which significantly enhances supply chain transparency."
Expansion of Product Applications
Clinical Applications of TB500
In sports medicine, TB500 is used to treat Achilles tendon injuries in professional athletes, reducing recovery time by 50%. In the treatment of diabetic foot ulcers, it accelerates healing by 40%. In the cardiovascular field, when combined with stem cell therapy for patients with myocardial infarction, it increases myocardial regeneration efficiency by 30%. Particularly in the area of neural repair, in a rat model of spinal cord injury, TB500 improved motor function recovery scores by 40%.
Multi-Indications Development of Retatrutide
In the field of metabolic diseases, Retatrutide is used for the treatment of type 2 diabetes, obesity, and MASLD. In terms of cardiovascular protection, in patients with hypertension, the 12 mg dose group reduced systolic blood pressure by 15 mmHg. In the field of neurodegenerative diseases, in a mouse model of Alzheimer's disease, the 8 mg dose group reduced β-amyloid deposition by 35%. Specifically in the field of cancer treatment, when used in combination with immune checkpoint inhibitors, tumor shrinkage rates increased by 20%.
